by Elena Iemma | May 13, 2021 | News
PROVIDENCE, RI, May 13, 2021 /PRNewswire/ — EpiVax Therapeutics, Inc. (“EVT”) announces the publication “Multi‑step screening of neoantigens’ HLA and TCR‑interfaces improves prediction of survival” in Scientific Reports. This study demonstrates a superior method...
by Elena Iemma | Feb 17, 2021 | Events, Webinars
EpiVax CEO/CSO Annie De Groot hosted a talk for the FDA Office of Tissues and Advanced Therapies (OTAT) group on February 11, 2021. Annie presented the latest on EpiVax’s iVAX Toolkit in her talk “Epitope Selection for Cancer Vaccines”. JanusMatrix,...
by Annie De Groot | Jun 28, 2019 | Events
5th CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference CICON 2019: Translating Science into Survival Wednesday, September 25 – Saturday, September 28 Espace Grande Arche de la Defense Parvis de la Défense 92044 Paris, France Members of EpiVax...
by Annie De Groot | Jun 28, 2019 | Events
7th Annual Cambridge Healthtech Institute’s Immuno-Oncology Summit Powering Next Generation Targeted Immunotherapies Monday, August 5th – Friday August 9th Westin Boston Waterfront 425 Summer Street Boston, MA 02210 UPDATE: EpiVax Oncology (EO) would like...
by Annie De Groot | Mar 29, 2019 | Events
CIMT 2019 Annual Meeting Tuesday, May 21st – Thursday, May 23rd Rheingoldhalle Congress Center Mainz, Germany Meet members of EpiVax Oncology at the 2019 CIMT meeting, scheduled from May 21-23 at the Rheingoldhalle Congress Center in Mainz, Germany. Every year,...
